Form Bio Co. Ltd. Net Assets
Form Bio Co. Ltd. net assets. Based on the latest financial reports, Form Bio Co. Ltd. (377220) has net assets worth ₩21.22 Billion KRW (≈ $14.38 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩60.86 Billion ≈ $41.24 Million USD) and total liabilities (₩39.64 Billion ≈ $26.86 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of Form Bio Co. Ltd. to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩21.22 Billion |
| % of Total Assets | 34.86% |
| Annual Growth Rate | N/A |
| 5-Year Change | -69.04% |
| 10-Year Change | N/A |
| Growth Volatility | 113.38 |
Net Assets of Form Bio Co. Ltd. (2019–2025)
Net assets of Form Bio Co. Ltd. from 2019 to 2025. This chart illustrates how Form Bio Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. See 377220 net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Form Bio Co. Ltd. (2019–2025)
The table below shows the annual net assets of Form Bio Co. Ltd. from 2019 to 2025. For live market cap and overall valuation, see Form Bio Co. Ltd. market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩26.14 Billion ≈ $17.71 Million |
-46.77% |
| 2024-12-31 | ₩49.10 Billion ≈ $33.28 Million |
-34.68% |
| 2023-12-31 | ₩75.17 Billion ≈ $50.94 Million |
-14.54% |
| 2022-12-31 | ₩87.96 Billion ≈ $59.61 Million |
+4.18% |
| 2021-12-31 | ₩84.43 Billion ≈ $57.22 Million |
+257.14% |
| 2020-12-31 | ₩23.64 Billion ≈ $16.02 Million |
+331.53% |
| 2019-12-31 | ₩-10.21 Billion ≈ $-6.92 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Form Bio Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 211160375000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Form Bio Co. Ltd. Net Assets Breakdown (December 2025)
Form Bio Co. Ltd. net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩52.26 Billion | 186.47% |
| Total Equity | ₩28.03 Billion | 100.00% |
Form Bio Co. Ltd. Competitors by Market Cap
The table below lists competitors of Form Bio Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Baosheng Media Group Holdings Ltd
NASDAQ:BAOS
|
$5.68 Million |
|
Media Lab SpA
PA:MLLAB
|
$5.69 Million |
|
E Investment & Development
KO:093230
|
$5.69 Million |
|
RareX Limited
F:CK1
|
$5.69 Million |
|
Chukai Public Company Limited
BK:CRANE
|
$5.67 Million |
|
Utilico Emerging Markets Ltd
LSE:UEM
|
$5.67 Million |
|
ARIP Public Company Limited
BK:ARIP
|
$5.66 Million |
|
Pacific Ridge Exploration Ltd
V:PEX
|
$5.66 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Form Bio Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 50,243,452,900 to 28,026,190,570, a change of -22,217,262,330 (-44.2%).
- Net loss of 22,457,152,320 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-22.46 Billion | -80.13% |
| Other Changes | ₩239.89 Million | +0.86% |
| Total Change | ₩- | -44.22% |
Book Value vs Market Value Analysis
This analysis compares Form Bio Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.30x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ₩-738.01 | ₩1480.00 | x |
| 2020-12-31 | ₩1708.72 | ₩1480.00 | x |
| 2021-12-31 | ₩5964.50 | ₩1480.00 | x |
| 2022-12-31 | ₩6213.73 | ₩1480.00 | x |
| 2023-12-31 | ₩2707.34 | ₩1480.00 | x |
| 2024-12-31 | ₩8873.80 | ₩1480.00 | x |
| 2025-12-31 | ₩4949.87 | ₩1480.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Form Bio Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -80.13%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -31.12%
- • Asset Turnover: 1.11x
- • Equity Multiplier: 2.33x
- Recent ROE (-80.13%) is below the historical average (-22.99%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -33.98% | 2.55x | 0.00x | ₩-20.00 Billion |
| 2020 | -33.05% | -7.23% | 2.40x | 1.90x | ₩-10.18 Billion |
| 2021 | 13.36% | 8.35% | 1.40x | 1.14x | ₩2.84 Billion |
| 2022 | 3.68% | 3.26% | 1.06x | 1.07x | ₩-5.56 Billion |
| 2023 | -14.45% | -16.60% | 0.69x | 1.27x | ₩-18.74 Billion |
| 2024 | -50.33% | -37.64% | 0.83x | 1.62x | ₩-30.31 Billion |
| 2025 | -80.13% | -31.12% | 1.11x | 2.33x | ₩-25.26 Billion |
Industry Comparison
This section compares Form Bio Co. Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $519,859,440,456
- Average return on equity (ROE) among peers: 4.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Form Bio Co. Ltd. (377220) | ₩21.22 Billion | 0.00% | 1.87x | $5.68 Million |
| Daehan Flour Mills Co Ltd (001130) | $558.82 Billion | 0.93% | 0.51x | $11.94 Million |
| Daesang Corp (001680) | $353.96 Billion | 0.00% | 2.25x | $401.28 Million |
| Daesang Corp Preference Shares (001685) | $1.02 Trillion | 10.49% | 1.35x | $12.83 Million |
| Korea Ind (002140) | $105.65 Billion | 0.65% | 1.60x | $29.51 Million |
| Choheung (002600) | $145.74 Billion | 11.03% | 0.84x | $56.88 Million |
| Sam Yang Foods (003230) | $395.69 Billion | 14.24% | 0.90x | $6.01 Billion |
| Daejoo Inc (003310) | $45.76 Billion | 2.57% | 0.78x | $34.54 Million |
| Harim Holdings Co. Ltd (003380) | $1.69 Trillion | 3.23% | 4.53x | $765.90 Million |
| Hansung Ent (003680) | $53.05 Billion | -0.09% | 3.35x | $12.75 Million |
| Namyang Dairy (003920) | $823.93 Billion | 0.02% | 0.17x | $166.49 Million |
About Form Bio Co. Ltd.
From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.